Phenotype of CD56+ cells derived from UCB/ACF, UCB/CD14+, UCB/CD34+, and UCB/CD56+cells after 30 days in culture
| . | ACF . | CD14+ . | CD34+ . | CD56+ . |
|---|---|---|---|---|
| CD7 | 99 ± 1 | 99 ± 1 | 62 ± 10 | 100( ± 1) |
| CD2 | 68 ± 7 | 73 ± 6 | 8 ± 3 | 80 ± 5 |
| CD8 | 51 ± 6 | 36 ± 10 | 15 ± 4 | 52 ± 3 |
| CD25 | 80 ± 7 | 75 ± 5 | 76 ± 3 | 79 ± 7 |
| CD117 | 18 ± 10 | 20 ± 8 | 45 ± 10 | 21 ± 6 |
| CD16 | 48 ± 9 | 38 ± 8 | 20 ± 6 | 41 ± 10 |
| CD161 | 7 ± 3 | 10 ± 4 | 68 ± 5 | 5 ± 4 |
| CD94 | 95 ± 2 | 95 ± 3 | 32 ± 2 | 96 ± 1 |
| CD158α | 22 ± 8 | 17 ± 5 | 1 ± 1 | 23 ± 5 |
| CD158b | 36 ± 11 | 28 ± 11 | 5 ± 3 | 35 ± 7 |
| . | ACF . | CD14+ . | CD34+ . | CD56+ . |
|---|---|---|---|---|
| CD7 | 99 ± 1 | 99 ± 1 | 62 ± 10 | 100( ± 1) |
| CD2 | 68 ± 7 | 73 ± 6 | 8 ± 3 | 80 ± 5 |
| CD8 | 51 ± 6 | 36 ± 10 | 15 ± 4 | 52 ± 3 |
| CD25 | 80 ± 7 | 75 ± 5 | 76 ± 3 | 79 ± 7 |
| CD117 | 18 ± 10 | 20 ± 8 | 45 ± 10 | 21 ± 6 |
| CD16 | 48 ± 9 | 38 ± 8 | 20 ± 6 | 41 ± 10 |
| CD161 | 7 ± 3 | 10 ± 4 | 68 ± 5 | 5 ± 4 |
| CD94 | 95 ± 2 | 95 ± 3 | 32 ± 2 | 96 ± 1 |
| CD158α | 22 ± 8 | 17 ± 5 | 1 ± 1 | 23 ± 5 |
| CD158b | 36 ± 11 | 28 ± 11 | 5 ± 3 | 35 ± 7 |
Values represent the percentage of positive cells (means ± SDs) from 5 different UCB samples tested.